中心梯度的变化与接受过导管边缘到边缘修复的患者的结果有关
Roni Sraya1, Itshak Amsalem2, Shemy Carasso2
1Jesselson Integrated Heart Center, Shaare Zedek Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel; Department of Military Medicine, Hebrew University of Jerusalem, Tzameret Program, Israel.
International journal of cardiology
|January 11, 2024
概括
通过导管边缘到边缘修复 (TEER) 进行 mitra regurgitation (MR) 可以增加 mitra 梯度 (MVG). 在MVG手术后更高的变化与一年内心力衰竭住院病例的增加有关.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 过导管边缘到边缘修复 (TEER) 是高风险患者重度额头吐 (MR) 的关键治疗方法.
- 在TEER之后,手术后额头梯度 (MVG) 的增加可能会对患者的结果产生负面影响,包括死亡率和住院治疗.
研究的目的:
- 在TEER之后评估绝对的手术后MVG.
- 为了比较绝对MVG和MVG变化 (delta MVG) 对患者结局的影响,特别是死亡率和心力衰竭住院治疗 (HFH).
主要方法:
- 分析了100名接受TEER治疗严重MR的患者队列.
- 患者根据绝对的术后MVG和MVG的变化 (术前到术后) 进行了分层.
- 主要终点是所有原因的死亡率和TEER后一年的HFH.
主要成果:
- 平均MVG从手术后立即增加到第二天 (3.39 mmHg到4.83 mmHg).
- 通过绝对的手术后MVG (>5 mmHg vs. ≤5 mmHg) 的分层显示,生存率或HFH率没有显著差异.
- 根据三角形MVG (≥3 mmHg vs. <3 mmHg) 的分层显示,≥3 mmHg的三角形MVG与明显更高的高血压率 (35.6% vs. 12.7%,p=0.014) 相关.
结论:
- 与手术后立即相比,中枢梯度通常在TEER后的第二天增加.
- 在TEER之后,MVG (delta MVG ≥3 mmHg) 的较大增加是心力衰竭在一年内增加住院治疗的显著预测因素.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


